Search

Home > OIS Podcast > What Does TearScience Deal Mean for J&J? Group Chair Ashley McEvoy Shines Light on Future Plans
Podcast: OIS Podcast
Episode:

What Does TearScience Deal Mean for J&J? Group Chair Ashley McEvoy Shines Light on Future Plans
Category: Business
Duration: 00:12:04
Publish Date: 2017-08-07 23:00:00
Description: Last week, Johnson & Johnson announced plans to acquire TearScience, maker of a line of products capable of diagnosing and treating Meibomian gland dysfunction, a leading cause of Dry Eye. Ashley McEvoy , Company Group Chairman for Johnson & Johnson Vision, explains where TearScience will fit into J&J if the deal is completed and what the global giant’s plans for additional Dry Eye treatments may be.
Total Play: 0